PhosCan Granted Extension of TSX Delisting Review
(firmenpresse) - TORONTO, ONTARIO -- (Marketwired) -- 11/30/15 -- PhosCan Chemical Corp. (TSX: FOS) ("PhosCan" or the "Company") announces that the Toronto Stock Exchange ("TSX") has notified the Company that TSX has decided to extend its review of the eligibility of the Company's common shares for continued listing for a period of 60 days.
Forward-Looking Statements
Certain statements in this press release may constitute "forward-looking" statements that involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of PhosCan to be materially different from any future results, performance or achievements expressed or implied by such forward looking statements. These forward-looking statements are made as of the date of this press release, and PhosCan assumes no obligations to update or revise them to reflect new events or circumstances.
Contacts:
PhosCan Chemical Corp.
Stephen Case
President & CEO
(416) 972-9222
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 30.11.2015 - 22:20 Uhr
Sprache: Deutsch
News-ID 436465
Anzahl Zeichen: 0
contact information:
Town:
TORONTO, ONTARIO
Kategorie:
Specialty Chemicals
Diese Pressemitteilung wurde bisher 232 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"PhosCan Granted Extension of TSX Delisting Review"
steht unter der journalistisch-redaktionellen Verantwortung von
PhosCan Chemical Corp. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
